Skip to main content

Table 3 Analysis of the primary outcome of continuous abstinence at 12 months

From: Effectiveness of a pharmacist-delivered smoking cessation program in the State of Qatar: a randomized controlled trial

 

Self-reported 12 months abstinence at the final visit

 

Continuous abstinence at 12 months (using all data from 3 visits)

 
 

OR (95% confidence interval)

p-value

OR (95% confidence interval)

p-value

Unadjusted OR

1.54 (0.73, 3.29)

0.259

1.58 (0.53, 4.70)

0.414

Adjusted ORa

1.54 (0.80, 2.99)

0.196

1.58 (0.45, 5.58)

0.480

Adjusted ORb

1.62 (0.65, 4.04)

0.297

1.86 (0.49, 7.07)

0.364

Adjusted ORc

1.60 (0.65, 3.87)

0.306

1.60 (0.43, 5.90)

0.483

Adjusted ORd

1.37 (0.67, 2.80)

0.393

1.34 (0.47, 3.85)

0.589

  1. aadjusted for clustering effect within pharmacists badjusted for years of smoking, cigarettes per day, tried quitting before, diabetes and nationality cadjusted for the number of monitoring visits the participants attended dall those lost to follow up were considered as smokers